drugset / Trial / NCT03196349
Comparison of Oral Anticoagulants for Extended VEnous Thromboembolism
Phase 4
Terminated
44 enrolled
Duke University
Patient-Centered Outcomes Research Institute · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
Comparison of Oral anticoagulants (warfarin, apixaban and rivaroxaban) for extended VEnous Thromboembolism.
Timeline
- Start
- 2018-08-01
- Primary completion
- 2019-05-01
- Completion
- 2019-05-01
Outcome
Outcome not reported
Stopped (Enrollment): “Lack of enrollment”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Apixaban | Small molecule | 2.5 mg | — |
| Comparator | Rivaroxaban | Other / unclassified | 10 mg | — |
| Comparator | Warfarin | Small molecule | — | — |